Transthyretin Amyloidosis Treatment Market Size Report, 2032

The transthyretin amyloidosis treatment market size was valued at USD 5.9 billion in 2023 and is expected to reach USD 11.2 billion by 2032 owing to increasing prevalence of transthyretin amyloidosis cases.

2023年，转甲状腺素蛋白淀粉样变性治疗市场规模达到590亿美元，预计到2032年将增至1120亿美元，这一增长得益于转甲状腺素蛋白淀粉样变性病例的日益增多。